Diaceutics PLC (AIM: DXRX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
117.10
-1.40 (-1.18%)
Nov 21, 2024, 2:26 PM GMT+1

Diaceutics Company Description

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories.

It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports.

In addition, the company offers professional services, such as market landscape, implementation, and consulting services.

Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Diaceutics PLC
Country United Kingdom
Founded 2005
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 184
CEO Ryan Keeling

Contact Details

Address:
Building Two
Belfast, BT9 6GW
United Kingdom
Website diaceutics.com

Stock Details

Ticker Symbol DXRX
Exchange London Stock Exchange AIM
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB00BJQTGV64
SIC Code 8731

Key Executives

Name Position
Ryan Keeling Chief Executive Officer
Nicholas Roberts Chief Financial Officer